Comparison 2
Praziquantel vs placebo or no drug
| Outcome or subgroup title | No. of studies | No. of participants | Statistical method | Effect size |
|---|---|---|---|---|
| 1 Symptoms not resolved after 3 months | 1 | Risk Ratio (M‐H, Fixed, 95% CI) | Totals not selected | |
| 2 Persistence of lesions at follow up | 1 | 15 | Risk Ratio (M‐H, Fixed, 95% CI) | 0.35 [0.14, 0.85] |
| 3 No reduction in number of lesions at 3 months | 1 | Risk Ratio (M‐H, Fixed, 95% CI) | Totals not selected | |
| 4 Any adverse events during treatment | 1 | Risk Ratio (M‐H, Fixed, 95% CI) | Totals not selected |